A gene therapy approach for the treatment of amyotrophic lateral sclerosis and Parkinson's disease

Adv Pharmacol. 1998:42:929-31. doi: 10.1016/s1054-3589(08)60899-6.
No abstract available

MeSH terms

  • Amyotrophic Lateral Sclerosis / therapy*
  • Animals
  • Cell Line
  • Ciliary Neurotrophic Factor
  • Cricetinae
  • Disease Models, Animal
  • Gene Transfer Techniques
  • Genetic Therapy*
  • Glial Cell Line-Derived Neurotrophic Factor
  • Humans
  • Nerve Growth Factors / biosynthesis*
  • Nerve Tissue Proteins / biosynthesis
  • Nerve Tissue Proteins / genetics
  • Parkinson Disease / therapy*
  • Rats
  • Recombinant Fusion Proteins / biosynthesis
  • Transfection

Substances

  • Ciliary Neurotrophic Factor
  • GDNF protein, human
  • Gdnf protein, rat
  • Glial Cell Line-Derived Neurotrophic Factor
  • Nerve Growth Factors
  • Nerve Tissue Proteins
  • Recombinant Fusion Proteins